Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy

J Am Coll Cardiol. 2004 May 5;43(9):1715-20. doi: 10.1016/j.jacc.2004.03.004.

Abstract

Objectives: We report on the initiation of ventricular fibrillation (VF) storm in patients with ischemic cardiomyopathy (ICM) and the results of targeted ablation to treat VF storm.

Background: Monomorphic premature ventricular contractions (PVCs) have been shown to initiate VF in patients without structural heart disease.

Methods: A total of 29 patients with ICM and documented VF initiation were identified. In 21 patients, VF storm was controlled with antiarrhythmic drugs and/or treatment of heart failure. Eight patients with VF (mean 52 +/- 25 episodes) refractory to medical management required ablation. All patients underwent three-dimensional electroanatomical mapping using CARTO (Biosense-Webster Inc., Diamond Bar, California), and PVCs were mapped when present. Scarred areas were identified using voltage mapping.

Results: Monomorphic PVCs initiated VF in all 29 identified patients. Five of eight patients requiring ablation had frequent PVCs that allowed PVC mapping. The earliest activation site was consistently located in the scar border zone. The PVCs were always preceded by a Purkinje-like potential (PLP). Ablation was successfully performed at these sites. In three patients, infrequent PVCs prevented mapping, but PLPs were recorded around the scar border. Ablation targeting these potentials along the scar border was successfully performed. During follow-up (10 +/- 6 months), one patient had a single VF episode and another developed sustained, monomorphic ventricular tachycardia. There was no recurrence of VF storm.

Conclusions: Ventricular fibrillation in ICM is triggered by monomorphic PVCs originating from the scar border zone with preceding PLPs; targeting these PVCs may prevent VF recurrence. In the absence of PVCs, both substrate mapping and ablation appear to be equally effective.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Aged
  • Anti-Arrhythmia Agents / therapeutic use
  • Body Surface Potential Mapping
  • Cardiomyopathies / physiopathology
  • Cardiomyopathies / therapy*
  • Catheter Ablation*
  • Defibrillators, Implantable
  • Electrophysiologic Techniques, Cardiac
  • Female
  • Follow-Up Studies
  • Heart Conduction System / physiopathology
  • Heart Conduction System / surgery
  • Heart Failure / physiopathology
  • Heart Failure / therapy
  • Humans
  • Male
  • Middle Aged
  • Myocardial Contraction / physiology
  • Myocardial Ischemia / physiopathology
  • Myocardial Ischemia / therapy*
  • Stroke Volume / physiology
  • Treatment Outcome
  • Ventricular Fibrillation / physiopathology
  • Ventricular Fibrillation / therapy*

Substances

  • Anti-Arrhythmia Agents